198 related articles for article (PubMed ID: 35392482)
1. Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations.
Baliakas P; Espinet B; Mellink C; Jarosova M; Athanasiadou A; Ghia P; Kater AP; Oscier D; Haferlach C; Stamatopoulos K
Hemasphere; 2022 Apr; 6(4):e707. PubMed ID: 35392482
[TBL] [Abstract][Full Text] [Related]
2. Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia.
Cavallari M; Cavazzini F; Bardi A; Volta E; Melandri A; Tammiso E; Saccenti E; Lista E; Quaglia FM; Urso A; Laudisi M; Menotti E; Formigaro L; Dabusti M; Ciccone M; Tomasi P; Negrini M; Cuneo A; Rigolin GM
Oncotarget; 2018 Sep; 9(76):34398-34412. PubMed ID: 30344950
[TBL] [Abstract][Full Text] [Related]
3. [Chromosomal aberrations detection in chronic lymphocytic leukemia by conventional cytogenetics using DSP30 and IL-2].
Liu HF; Huang HW; Bai SX; Gong YL; Wu CX; Jin ZM; Wang YY; Yang Q; Zhang J; Qiu HY; Chen SN; Pan JL
Zhonghua Xue Ye Xue Za Zhi; 2020 Feb; 41(2):143-148. PubMed ID: 32135632
[No Abstract] [Full Text] [Related]
4. Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL).
Puiggros A; Ramos-Campoy S; Kamaso J; de la Rosa M; Salido M; Melero C; Rodríguez-Rivera M; Bougeon S; Collado R; Gimeno E; García-Serra R; Alonso S; Moro-García MA; García-Malo MD; Calvo X; Arenillas L; Ferrer A; Mantere T; Hoischen A; Schoumans J; Espinet B
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884436
[TBL] [Abstract][Full Text] [Related]
5. Biology and Treatment of High-Risk CLL: Significance of Complex Karyotype.
Chatzikonstantinou T; Demosthenous C; Baliakas P
Front Oncol; 2021; 11():788761. PubMed ID: 34912723
[TBL] [Abstract][Full Text] [Related]
6. Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia.
Chun K; Wenger GD; Chaubey A; Dash DP; Kanagal-Shamanna R; Kantarci S; Kolhe R; Van Dyke DL; Wang L; Wolff DJ; Miron PM
Cancer Genet; 2018 Dec; 228-229():236-250. PubMed ID: 30554732
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary diagnostics of chronic lymphocytic leukemia: European Research Initiative on CLL - ERIC recommendations.
Zalcberg I; D'Andrea MG; Monteiro L; Pimenta G; Xisto B
Hematol Transfus Cell Ther; 2020; 42(3):269-274. PubMed ID: 31784406
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.
Baliakas P; Jeromin S; Iskas M; Puiggros A; Plevova K; Nguyen-Khac F; Davis Z; Rigolin GM; Visentin A; Xochelli A; Delgado J; Baran-Marszak F; Stalika E; Abrisqueta P; Durechova K; Papaioannou G; Eclache V; Dimou M; Iliakis T; Collado R; Doubek M; Calasanz MJ; Ruiz-Xiville N; Moreno C; Jarosova M; Leeksma AC; Panayiotidis P; Podgornik H; Cymbalista F; Anagnostopoulos A; Trentin L; Stavroyianni N; Davi F; Ghia P; Kater AP; Cuneo A; Pospisilova S; Espinet B; Athanasiadou A; Oscier D; Haferlach C; Stamatopoulos K;
Blood; 2019 Mar; 133(11):1205-1216. PubMed ID: 30602617
[TBL] [Abstract][Full Text] [Related]
9. Examination of clonal evolution in chronic lymphocytic leukemia.
Koczkodaj D; Popek-Marciniec S; Zmorzyński S; Wąsik-Szczepanek E; Filip AA
Med Oncol; 2019 Aug; 36(9):79. PubMed ID: 31375939
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes.
Döhner H; Stilgenbauer S; Fischer K; Bentz M; Lichter P
Leukemia; 1997 Apr; 11 Suppl 2():S19-24. PubMed ID: 9178833
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic methods in chronic lymphocytic leukemia.
Haferlach C; Bacher U
Methods Mol Biol; 2011; 730():119-30. PubMed ID: 21431638
[TBL] [Abstract][Full Text] [Related]
12. Clonal evolution in chronic lymphocytic leukemia detected by fluorescence in situ hybridization and conventional cytogenetics after stimulation with CpG oligonucleotides and interleukin-2: a prospective analysis.
Brejcha M; Stoklasová M; Brychtová Y; Panovská A; Štěpanovská K; Vaňková G; Plevová K; Oltová A; Horká K; Pospíšilová Š; Mayer J; Doubek M
Leuk Res; 2014 Feb; 38(2):170-5. PubMed ID: 24246692
[TBL] [Abstract][Full Text] [Related]
13. Analytical and clinical performance of chromosomal microarrays compared with FISH panel and conventional karyotyping in patients with chronic lymphocytic leukemia.
Tang Z; Kanagal-Shamanna R; Tang G; Patel K; Medeiros LJ; Toruner GA
Leuk Res; 2021 Sep; 108():106616. PubMed ID: 34022744
[TBL] [Abstract][Full Text] [Related]
14. ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-2024 update.
Malcikova J; Pavlova S; Baliakas P; Chatzikonstantinou T; Tausch E; Catherwood M; Rossi D; Soussi T; Tichy B; Kater AP; Niemann CU; Davi F; Gaidano G; Stilgenbauer S; Rosenquist R; Stamatopoulos K; Ghia P; Pospisilova S
Leukemia; 2024 May; ():. PubMed ID: 38755420
[TBL] [Abstract][Full Text] [Related]
15. Cytogenetic landscape in 1012 newly diagnosed chronic lymphocytic leukemia.
Senouci A; Smol T; Tricot S; Bakala J; Moulessehoul S; Quilichini B; Penther D; Herbaux C; Daudignon A
Eur J Haematol; 2019 Dec; 103(6):607-613. PubMed ID: 31512291
[TBL] [Abstract][Full Text] [Related]
16. Precise determination of primary cytogenetic abnormalities provides added value for stratification of chronic lymphocytic leukemia patients.
Dvorak P; Lysak D; Vohradska P; Subrt I
Neoplasma; 2019 Jan; 66(1):128-139. PubMed ID: 30509088
[TBL] [Abstract][Full Text] [Related]
17. The parallel application of karyotype interphase and metaphase FISH after DSP-30/IL-2 stimulation is necessary for the investigation of chronic lymphocytic leukemia.
Karakosta M; Manola KN
Hematology; 2016 Oct; 21(9):526-35. PubMed ID: 27077766
[TBL] [Abstract][Full Text] [Related]
18. ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation.
Malcikova J; Tausch E; Rossi D; Sutton LA; Soussi T; Zenz T; Kater AP; Niemann CU; Gonzalez D; Davi F; Gonzalez Diaz M; Moreno C; Gaidano G; Stamatopoulos K; Rosenquist R; Stilgenbauer S; Ghia P; Pospisilova S;
Leukemia; 2018 May; 32(5):1070-1080. PubMed ID: 29467486
[TBL] [Abstract][Full Text] [Related]
19. Clinicobiologic importance of cytogenetic lesions in chronic lymphocytic leukemia.
Cavazzini F; Ciccone M; Negrini M; Rigolin GM; Cuneo A
Expert Rev Hematol; 2009 Jun; 2(3):305-14. PubMed ID: 21082972
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL Registry.
Mato A; Nabhan C; Kay NE; Lamanna N; Kipps TJ; Grinblatt DL; Flowers CR; Farber CM; Davids MS; Kiselev P; Swern AS; Bhushan S; Sullivan K; Flick ED; Sharman JP
Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):114-124.e2. PubMed ID: 29352719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
